Generic: Doxycycline Monohydrate | Manufacturer: Overall
| Year | Total Spending | Claims | Beneficiaries | Cost/Unit |
|---|---|---|---|---|
| 2019 | $4.4M | 3,874 | 1,092 | $23.24 |
| 2020 | $3.9M | 3,344 | 878 | $24.04 |
| 2021 | $3.6M | 2,995 | 825 | $25.67 |
| 2022 | $3.4M | 2,770 | 755 | $26.62 |
| 2023 | $3.9M | 3,150 | 905 | $28.31 |
| State | Total Drug Cost | Claims | Prescribers | Beneficiaries |
|---|---|---|---|---|
| California | $520.7K | 402 | 135 | 127 |
| New York | $392.9K | 328 | 82 | 99 |
| Texas | $333.3K | 291 | 81 | 80 |
| Maryland | $320.6K | 282 | 63 | 75 |
| Florida | $258.1K | 182 | 60 | 56 |
| Pennsylvania | $197.1K | 133 | 36 | 37 |
| Illinois | $180.1K | 151 | 35 | 33 |
| Georgia | $158.9K | 146 | 33 | 37 |
| North Carolina | $142.5K | 133 | 34 | 33 |
| Virginia | $136.6K | 92 | 21 | 25 |
| Massachusetts | $120.0K | 84 | 23 | 23 |
| New Jersey | $114.3K | 77 | 23 | 23 |
| Ohio | $88.1K | 70 | 23 | 22 |
| Connecticut | $75.2K | 51 | 17 | 18 |
| South Carolina | $72.1K | 61 | 14 | 14 |
| Alaska | $53.3K | 33 | 10 | 14 |
| Alabama | $53.0K | 47 | 13 | 15 |
| Delaware | $47.6K | 32 | 6 | N/A |
| Colorado | $47.5K | 41 | 13 | 13 |
| Arizona | $43.9K | 38 | 13 | 12 |
| Michigan | $42.8K | 34 | 10 | N/A |
| Washington | $38.3K | 36 | 12 | 12 |
| Tennessee | $37.5K | 29 | 9 | N/A |
| Louisiana | $37.0K | 42 | 12 | 11 |
| New Hampshire | $34.4K | 15 | 5 | N/A |
| Oklahoma | $33.8K | 23 | 12 | N/A |
| Minnesota | $29.1K | 26 | 7 | N/A |
| Indiana | $28.0K | 26 | 6 | N/A |
| Nevada | $27.7K | 24 | 6 | N/A |
| Rhode Island | $25.4K | 29 | 5 | N/A |
| Oregon | $22.2K | 16 | 6 | N/A |
| West Virginia | $17.8K | 15 | 5 | N/A |
| Maine | $17.3K | 12 | 5 | N/A |
| South Dakota | $17.2K | 19 | 4 | N/A |
| Hawaii | $17.1K | 18 | 6 | N/A |
| New Mexico | $16.9K | 11 | 3 | N/A |
| Wisconsin | $13.0K | 14 | 2 | N/A |
| Puerto Rico | $12.7K | 15 | 7 | N/A |
| Kentucky | $11.5K | 12 | 6 | N/A |
| Missouri | $11.2K | 12 | 7 | N/A |
The DrugPricePeek editorial team aggregates and verifies drugs data from CMS NADAC & Medicare Part D. Every statistic on this site is cross-referenced against the official source before publication, with quarterly re-verification cycles.
Read our full methodology or contact us with corrections.
Explore More Data Tools
For adjacent public-data tools, methodology notes, and network updates, visit DataPeek Facts.